Persister cells

Annual Review of Microbiology

Volumn 64, Issue , 2010, Pages 357-372

  Lewis, Kim ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

antibiotic; antimicrobial tolerance; biofilm; resistance; stochasticity; stress response

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTITOXIN; CARBENICILLIN; CHLORHEXIDINE; CIPROFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; STREPTOTHRICIN; TETRACYCLINE; TOBRAMYCIN; TRANSCRIPTOME;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL CELL; BIOFILM; CANDIDA ALBICANS; CELL ISOLATION; CYSTIC FIBROSIS; DORMANCY; ESCHERICHIA COLI; GENE EXPRESSION; GENE OVEREXPRESSION; HELICOBACTER PYLORI; IMMUNE RESPONSE; INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERSISTER CELL; PRIORITY JOURNAL; PROTON MOTIVE FORCE; PSEUDOMONAS AERUGINOSA; REVIEW; TRANSCRIPTOMICS; TRANSPOSON;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, FUNGAL; ESCHERICHIA COLI; HUMANS; PSEUDOMONAS AERUGINOSA;

CANDIDA ALBICANS; ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

EID: 77955628762     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.112408.134306     Document Type: Review

References (93)

1. Al-Dhaheri RS, Douglas LJ. 2008. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob. Agents Chemother. 52:1884-87
2. Alix E, Blanc-Potard A. 2009. Hydrophobic peptides: novel regulators within bacterial membranes. Mol. Microbiol. 72:5-11
3. Avery SV. 2006. Microbial cell individuality and the underlying sources of heterogeneity. Nat. Rev. Microbiol. 4:577-87
4. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, et al. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2:1-11
5. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-25
6. Baltz RA. 2005. Antibiotic discovery from actinomycetes: Will a renaissance follow the decline and fall? SIM News 55:188-96
7. Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7:845-55
8. Bassler BL, Losick R. 2006. Bacterially speaking. Cell 125:237-46
9. Bayles KW. 2007. The biological role of death and lysis in biofilm development. Nat. Rev. Microbiol. 5:721-26
10. Berg HC, Brown DA. 1972. Chemotaxis in Escherichia coli analyzed by three-dimensional tracking. Nature 239 500-4
11. Bigger JW. 1944. Treatment of staphylococcal infections with penicillin. Lancet 244:497-500
12. Black DS, Irwin B, Moyed HS. 1994. Autoregulation of hip,anoperon that affects lethality duetoinhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 176:4081-91
13. Black DS, Kelly AJ, Mardis MJ, Moyed HS. 1991. Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 173:5732-39
14. Brooun A, Liu S, Lewis K. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-46
15. Chai Y, Chu F, Kolter R, Losick R. 2008. Bistability and biofilm formation in Bacillus subtilis.Mol. Microbiol. 67:254-63
16. Christensen SK, Gerdes K. 2003. RelE toxins from bacteria and archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. Mol. Microbiol. 48:1389-400
17. Chung JD, Stephanopoulos G, Ireton K, Grossman AD. 1994. Gene expression in single cells of Bacillus subtilis: evidence that a threshold mechanism controls the initiation of sporulation. J. Bacteriol. 176:1977-84
18. Correia FF, D'Onofrio A, Rejtar T, Li L, Karger BL, et al. 2006. Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J. Bacteriol. 188:8360-67
19. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-22
20. Courcelle J, Khodursky A, Peter B, Brown P, Hanawalt P. 2001. Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli. Genetics 158:41-64
21. Davis BD, Chen LL, Tai PC. 1986. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc. Natl. Acad. Sci. USA 83:6164-68
22. De Groote VN, Verstraeten N, Fauvart M, Kint CI, Verbeeck AM, et al. 2009. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 297:73-79
23. Del Pozo J, PatelR.2007. The challengeof treating biofilm-associated bacterial infections.Clin. Pharmacol. Ther. 82:204-9
24. Dörr T, Lewis K, Vulic M. 2009. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 5:e1000760
25. Dörr T, Vulić M, Lewis K. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. Plos. Biol. 8(2):e1000317
26. Dubnau D, Losick R. 2006. Bistability in bacteria. Mol. Microbiol. 61:564-72
27. Falla TJ, Chopra I. 1998. Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob. Agents Chemother. 42:3282-84
28. Fernandez De Henestrosa AR, Ogi T, Aoyagi S, Chafin D, Hayes JJ, et al. 2000. Identification of additional genes belonging to the LexA regulon in Escherichia coli. Mol. Microbiol. 35:1560-72
29. Garcia-Olmedo F, Molina A, Alamillo JM, Rodriguez-Palenzuela P. 1998. Plant defense peptides. Biopolymers 47:479-91
30. Gerdes K, Bech FW, Jorgensen ST, Lobner-Olesen A, Rasmussen PB, et al. 1986. Mechanism of post-segregational killing by the hok gene product of the parB system of plasmid R1 and its homology with the relF gene product of the E. coli relB operon. EMBO J. 5:2023-29
31. Gerdes K, Rasmussen PB, Molin S. 1986. Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. Proc. Natl. Acad. Sci. USA 83:3116-20
32. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-51
33. Gonzalez-Pastor JE, Hobbs EC, Losick R. 2003. Cannibalism by sporulating bacteria. Science 301:510-13
34. Hansen S, Lewis K, Vulić M. 2008. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob. Agents. Chemother. 52:2718-26
35. Harrison JJ, Ceri H, Roper NJ, Badry EA, Sproule KM, Turner RJ. 2005. Persister cells mediate tolerance to metal oxyanions in Escherichia coli. Microbiology 151:3181-95
36. Harrison JJ, Turner RJ, Ceri H. 2005. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ. Microbiol. 7:981-94
37. Harrison JJ, Turner RJ, Ceri H. 2007. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents. FEMS Microbiol. Lett. 272:172-81
38. Harrison JJ, Wade WD, Akierman S, Vacchi-Suzzi C, Stremick CA, et al. 2009. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob. Agents Chemother. 53:2253-58
39. Hayes F. 2003. Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301:1496-99
40. Honda H, Warren DK. 2009. Central nervous system infections: meningitis and brain abscess. Infect. Dis. Clin. North Am. 23:609-23
41. Hooper D. 2001. Mechanism of action of antimicrobials: focus on fluoroquinolones. Clin. Infect. Dis. 32:S9-15
42. Hu Y, Coates AR. 2005. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiol. Lett. 243:117-24
43. Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, et al. 2003. Compromised host defense on Pseu-domonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions.J. Immunol. 171:4329-39
44. Kaern M, Elston TC, Blake WJ, Collins JJ. 2005. Stochasticity in gene expression: from theories to phenotypes. Nat. Rev. Genet. 6:451-64
45. Kawano M, Aravind L, Storz G. 2007. An antisense RNA controls synthesis of an SOS-induced toxin evolved from an antitoxin. Mol. Microbiol. 64:738-54
46. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18
47. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-80
48. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810
49. Korch SB, Henderson TA, Hill TM. 2003. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol. Microbiol. 50:1199-213
50. Korch SB, Hill TM. 2006. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188:3826-36
51. Korobkova E, Emonet T, Vilar JM, Shimizu TS, Cluzel P. 2004. From molecular noise to behavioural variability in a single bacterium. Nature 428:574-78
52. LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal-tolerant per-sister cells. Antimicrob. Agents Chemother. 50:3839-46
53. Lafleur MD, Qi Q, Lewis K. 2010. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 54:39-44
54. Leid JG, Shirtliff ME, Costerton JW, Stoodley AP. 2002. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 70:6339-45
55. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10:S122-29
56. Lewis K. 2000. Programmed death in bacteria. Microbiol. Mol. Biol. Rev. 64:503-14
57. Lewis K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:999-1007
58. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48-56
59. Lewis K, Spoering A, Kaldalu N, Keren I, Shah D. 2005. Persisters: specialized cells responsible for biofilm tolerance to antimicrobial agents. In Biofilms, Infection, and Antimicrobial Therapy, ed. J Pace, ME Rupp, RG Finch, pp. 241-56. Boca Raton, FL: Taylor & Francis
60. Li Y, Zhang Y. 2007. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob. Agents Chemother. 51:2092-99
61. Maamar H, Raj A, Dubnau D. 2007. Noise in gene expression determines cell fate in Bacillus subtilis. Science 317:526-29
62. McKenzie MD, Lee PL, Rosenberg SM. 2003. The dinB operon and spontaneous mutation in Escherichia coli. J. Bacteriol. 185:3972-77
63. Motiejunaite R, Armalyte J, Markuckas A, Suziedeliene E. 2007. Escherichia coli dinJ-yafQ genes act as a toxin-antitoxin module. FEMS Microbiol. Lett. 268:112-19
64. Moyed HS, Bertrand KP. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768-75
65. Moyed HS, Broderick SH. 1986. Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 166:399-403
66. Mulcahy LR, Burns JL, Lory S, Lewis K. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. In press
67. Pandey DP, Gerdes K. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33:966-76
68. Pedersen K, Christensen SK, Gerdes K. 2002. Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45:501-10
69. Pedersen K, Gerdes K. 1999. Multiple hok genes on the chromosome of Escherichia coli. Mol. Microbiol. 32:1090-102
70. Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L. 2000. Helicobacter pylori-related disease: guidelines for testing and treatment. Arch. Intern. Med. 160:1285-91
71. Phillips I, Culebras E, Moreno F, Baquero F. 1987. Induction of the SOS response by new 4-quinolones. J. Antimicrob. Chemother. 20:631-38
72. Ramage HR, Connolly LE, Cox JS. 2009. Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet. 5:e1000767
73. Sahl HG, Bierbaum G. 1998. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu. Rev. Microbiol. 52:41-79
74. Scherrer R, Moyed HS. 1988. Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. J. Bacteriol. 170:3321-26
75. Schmelzle T, Hall MN. 2000. TOR, a central controller of cell growth. Cell 103:253-62
76. Schumacher MA, Piro KM, Xu W, Hansen S, Lewis K, Brennan RG. 2009. Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323:396-401
77. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 6:53-61
78. Singh R, Barry CE 3rd, Boshoff HIM. 2010. The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance. J. Bacteriol. 192:1279-91
79. Singletary LA, Gibson JL, Tanner EJ, McKenzie GJ, Lee PL, et al. 2009. An SOS-regulated type 2 toxin-antitoxin system. J. Bacteriol. 191:7456-65
80. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 103:8487-92
81. Spoering A. 2006. GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 188:5136-44
82. Spoering AL, Lewis K. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:6746-51
83. Spudich JL, KoshlandDEJr. 1976. Non-genetic individuality: chance in the single cell. Nature 262:467-71
84. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-38
85. Unoson C, Wagner E. 2008. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 70:258-70
86. Vazquez-Laslop N, Lee H, Neyfakh AA. 2006. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188:3494-97
87. Vogel J, Argaman L, Wagner EG, Altuvia S. 2004. The small RNA Istr inhibits synthesis of an SOS-induced toxic peptide. Curr. Biol. 14:2271-76
88. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, et al. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6:269-75
89. Walsh C. 2003. Antibiotics: Actions, Origins, Resistance. Washington, DC: ASM Press
90. Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47:317-23
91. Wiuff C, Zappala RM, Regoes RR, Garner KN, Baquero F, Levin BR. 2005. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49:1483-94
92. Wolfson JS, Hooper DC, McHugh GL, Bozza MA, Swartz MN. 1990. Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents. Antimicrob. Agents Chemother. 34:1938-43
93. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-95